138 related articles for article (PubMed ID: 17065101)
1. Analysis of pyrimidine synthesis de novo intermediates in urine during crisis of a patient with ornithine transcarbamylase deficiency.
van Kuilenburg AB; van Maldegem BT; Abeling NG; Wijburg FA; Duran M
Nucleosides Nucleotides Nucleic Acids; 2006; 25(9-11):1251-5. PubMed ID: 17065101
[TBL] [Abstract][Full Text] [Related]
2. Analysis of pyrimidine synthesis "de novo" intermediates in urine and dried urine filter- paper strips with HPLC-electrospray tandem mass spectrometry.
van Kuilenburg AB; van Lenthe H; Löffler M; van Gennip AH
Clin Chem; 2004 Nov; 50(11):2117-24. PubMed ID: 15375016
[TBL] [Abstract][Full Text] [Related]
3. [Chronic hyperammonemia with orotic aciduria: evidence of pyrimidine pathway stimulation (author's transl)].
Beaudry MA; Letarte J; Collu R; Leboeuf G; Ducharme JR; Melancon SB; Dallairf L
Diabete Metab; 1975 Mar; 1():29-37. PubMed ID: 1234064
[TBL] [Abstract][Full Text] [Related]
4. RC--a case of ornithine transcarbamylase (OTC) deficiency. The most commonly genetically acquired urea cycle defect.
Morra DR; Nadkarni VM; Bartoshesky LE; Finkelstein MS
Del Med J; 2000 Aug; 72(8):349-54. PubMed ID: 10984978
[No Abstract] [Full Text] [Related]
5. Ornithine transcarbamylase deficiency: ten new mutations and high proportion of de novo mutations in heterozygous females.
Oppliger Leibundgut E; Liechti-Gallati S; Colombo JP; Wermuth B
Hum Mutat; 1997; 9(5):409-11. PubMed ID: 9143919
[No Abstract] [Full Text] [Related]
6. A second pathway to degrade pyrimidine nucleic acid precursors in eukaryotes.
Andersen G; Björnberg O; Polakova S; Pynyaha Y; Rasmussen A; Møller K; Hofer A; Moritz T; Sandrini MP; Merico AM; Compagno C; Akerlund HE; Gojković Z; Piskur J
J Mol Biol; 2008 Jul; 380(4):656-66. PubMed ID: 18550080
[TBL] [Abstract][Full Text] [Related]
7. Urinary Uracil: A Useful Marker for Ornithine Transcarbamylase Deficiency in Affected Males.
Alsharhan H; Alharbi H; Priestley J; Ganetzky R; He M
Clin Chem; 2020 Jul; 66(7):988-989. PubMed ID: 32628763
[No Abstract] [Full Text] [Related]
8. First example of hepatocyte transplantation to alleviate ornithine transcarbamylase deficiency, monitored by NMR-based metabonomics.
Legido-Quigley C; Cloarec O; Parker DA; Murphy GM; Holmes E; Lindon JC; Nicholson JK; Mitry RR; Vilca-Melendez H; Rela M; Dhawan A; Heaton N
Bioanalysis; 2009 Dec; 1(9):1527-35. PubMed ID: 21083101
[TBL] [Abstract][Full Text] [Related]
9. Acrodermatitis enteropathica-like dermatosis associated with ornithine transcarbamylase deficiency.
Pascual JC; Matarredona J; Mut J
Pediatr Dermatol; 2007; 24(4):394-6. PubMed ID: 17845164
[TBL] [Abstract][Full Text] [Related]
10. Ornithine transcarbamylase and arginase I deficiency are responsible for diminished urea cycle function in the human hepatoblastoma cell line HepG2.
Mavri-Damelin D; Eaton S; Damelin LH; Rees M; Hodgson HJ; Selden C
Int J Biochem Cell Biol; 2007; 39(3):555-64. PubMed ID: 17098461
[TBL] [Abstract][Full Text] [Related]
11. Nitric oxide synthesis in ornithine transcarbamylase deficiency: possible involvement of low no synthesis in clinical manifestations of urea cycle defect.
Nagasaka H; Komatsu H; Ohura T; Sogo T; Inui A; Yorifuji T; Murayama K; Takayanagi M; Kikuta H; Kobayashi K
J Pediatr; 2004 Aug; 145(2):259-62. PubMed ID: 15289781
[TBL] [Abstract][Full Text] [Related]
12. Aminograms during continuous hemodiafiltration in the treatment of hyperammonemia due to ornithine transcarbamylase deficiency.
Chen CY; Tsai TC; Lee WJ; Chen HC
Ren Fail; 2007; 29(6):661-5. PubMed ID: 17763159
[TBL] [Abstract][Full Text] [Related]
13. [Trial of detection of female carriers for the ornithine-carbamyltransferase deficiency by the urine assay of crotic acid. Apropos of a family study].
Dhondt JL; Farriaux JP
Ann Genet; 1975 Sep; 18(3):197-202. PubMed ID: 1080984
[TBL] [Abstract][Full Text] [Related]
14. The sparse fur mouse: an animal model for a human inborn error of metabolism of the urea cycle.
Spector EB; Mazzocchi RA
Prog Clin Biol Res; 1983; 127():85-96. PubMed ID: 6889405
[No Abstract] [Full Text] [Related]
15. Successful living-donor liver transplantation from an asymptomatic carrier mother in ornithine transcarbamylase deficiency.
Nagasaka H; Yorifuji T; Egawa H; Kikuta H; Tanaka K; Kobayashi K
J Pediatr; 2001 Mar; 138(3):432-4. PubMed ID: 11241058
[TBL] [Abstract][Full Text] [Related]
16. Coagulopathy in patients with late-onset ornithine transcarbamylase deficiency in remission state: a previously unrecognized complication.
Ihara K; Yoshino M; Hoshina T; Harada N; Kojima-Ishii K; Makimura M; Hasegawa Y; Watanabe Y; Yamaguchi S; Hara T
Pediatrics; 2013 Jan; 131(1):e327-30. PubMed ID: 23209112
[TBL] [Abstract][Full Text] [Related]
17. Fatal cerebral edema from late-onset ornithine transcarbamylase deficiency in a juvenile male patient receiving valproic acid.
Thakur V; Rupar CA; Ramsay DA; Singh R; Fraser DD
Pediatr Crit Care Med; 2006 May; 7(3):273-6. PubMed ID: 16575347
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive analysis of pyrimidine metabolism in 450 children with unspecific neurological symptoms using high-pressure liquid chromatography-electrospray ionization tandem mass spectrometry.
Schmidt C; Hofmann U; Kohlmüller D; Mürdter T; Zanger UM; Schwab M; Hoffmann GF
J Inherit Metab Dis; 2005; 28(6):1109-22. PubMed ID: 16435204
[TBL] [Abstract][Full Text] [Related]
19. Ornithine transcarbamylase deficiency: case report and review.
Bueno JD; Lutz R; Cho S
Kans Med; 1995; 96(3):135-8. PubMed ID: 8583741
[No Abstract] [Full Text] [Related]
20. High-throughput tandem mass spectrometry multiplex analysis for newborn urinary screening of creatine synthesis and transport disorders, Triple H syndrome and OTC deficiency.
Auray-Blais C; Maranda B; Lavoie P
Clin Chim Acta; 2014 Sep; 436():249-55. PubMed ID: 24909877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]